Hemolytic anemia in a patient with hypertrophic obstructive cardiomyopathy

Journal of Cardiology

Volumn 55, Issue 1, 2010, Pages 125-129

  Kubo, Toru ^a   Kitaoka, Hiroaki ^a   Terauchi, Yasunobu ^a   Tamura, Shinjiro ^a   Okawa, Makoto ^a   Yamasaki, Naohito ^a   Yabe, Toshikazu ^a   Doi, Yoshinori L ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Hemodynamics; Hemolytic anemia; Hypertrophic obstructive cardiomyopathy

Indexed keywords

ATENOLOL; CIBENZOLINE;

AGED; ARTICLE; CASE REPORT; ECG ABNORMALITY; FEMALE; HEART OUTFLOW TRACT OBSTRUCTION; HEART VENTRICLE SEPTUM; HEMOGLOBIN BLOOD LEVEL; HEMOLYTIC ANEMIA; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; INTRAVASCULAR HEMOLYSIS; MITRAL VALVE REGURGITATION; NORMOCHROMIC NORMOCYTIC ANEMIA; SYSTOLIC HEART MURMUR; TRANSTHORACIC ECHOCARDIOGRAPHY;

AGED; ANEMIA, HEMOLYTIC; ANTI-ARRHYTHMIA AGENTS; ATENOLOL; CARDIOMYOPATHY, HYPERTROPHIC; ECHOCARDIOGRAPHY; FEMALE; HUMANS; IMIDAZOLES; MITRAL VALVE INSUFFICIENCY; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 72649093672     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2009.03.013     Document Type: Article

References (11)

1. Maron B.J., McKenna W.J., Danielson G.K., Kappenberger L.J., Kuhn H.J., Seidman C.E., Shah P.M., Spencer III W.H., Spirito P., Ten Cate F.J., Wigle E.D., Task Force on Clinical Expert Consensus Documents. American College of Cardiology, and Committee for Practice Guidelines. European Society of Cardiology. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42 (2003) 1687-1713
2. Harrison D.C., Braunwald E., Glick G., Mason D.T., Chidsey C.A., and Ross Jr. J. Effects of beta adrenergic blockade on the circulation with particular reference to observations in patients with hypertrophic subaortic stenosis. Circulation 29 (1964) 84-98
3. Maron M.S., Olivotto I., Betocchi S., Casey S.A., Lesser J.R., Losi M.A., Cecchi F., and Maron B.J. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 348 (2003) 295-303
4. Autore C., Bernabo P., Barilla C.S., Bruzzi P., and Spirito P. The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms. J Am Coll Cardiol 45 (2005) 1076-1080
5. Hamada M., Shigematsu Y., Ikeda S., Hara Y., Okayama H., Kodama K., Ochi T., and Hiwada K. Class Ia antiarrhythmic drug cibenzoline: a new approach to the medical treatment of hypertrophic obstructive cardiomyopathy. Circulation 96 (1997) 1520-1524
6. Pirofsky B. Hemolysis in valvular heart disease. Ann Int Med 65 (1966) 373-376
7. Okumiya T., Ishikawa-Nishi M., Doi T., Kamioka M., Takeuchi H., Doi Y., and Sugiura T. Evaluation of intravascular hemolysis with erhythrocyte creatine in patients with cardiac valve prostheses. Chest 125 (2004) 2115-2120
8. Solanki D.L., and Sheikh M.U. Fragmentation hemolysis in idiopathic hypertrophic subaortic stenosis. South Med J 71 (1978) 599-601
9. Zezulka A., Shapiro L., and Singh S. Chronic haemolytic anaemia in hypertrophic cardiomyopathy. Br Heart J 52 (1984) 474-476
10. Maeda T., Ashie T., Kikuiri K., Fukuyama S., Yamaguchi Y., Yoshida E., Shimamoto K., and Iimura O. Fragmentation hemolysis in a patient with hypertrophic obstructive cardiomyopathy and mitral valve prolapse. Jpn Circ J 56 (1992) 970-974
11. Palaez-Dominguez S., Perez-Benito L., Sanz Moreno J., Garcia Calvo I., Ruiz Morales J., and Palomo Bravo A. Severe hemolytic anemia in hypertrophic cardiomyopathy. Am Heart J 124 (1992) 1082-1083